IPW
DFTX

Impact Partnership Wealth’s Definium Therapeutics DFTX Stock Holding History

Impact Partnership Wealth’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-48
Closed -$150 – 1005
2023
Q3 		$150 Hold
48
– – ﹤0.01% 966
2023
Q2 		$171 Buy
+48
New +$166 ﹤0.01% 885

Other funds holding DFTX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Impact Partnership Wealth's DFTX Position: Q4 2023 in Review

Impact Partnership Wealth sold out of Definium Therapeutics (DFTX) in Q4 2023, closing a stake of 48 shares — an estimated $150 sold.

Impact Partnership Wealth first reported a position in DFTX in Q2 2023 and held it in 2 quarters. The position peaked at $171 in Q2 2023. 104 funds tracked by Wall St. Rank hold DFTX as of Q4 2023.

  • Impact Partnership Wealth reported no remaining Definium Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Impact Partnership Wealth sold 48 Definium Therapeutics shares in Q4 2023, an estimated $150.
  • Impact Partnership Wealth first reported a position in Definium Therapeutics in Q2 2023 and held it in 2 quarters.
  • Impact Partnership Wealth's Definium Therapeutics position peaked at $171 in Q2 2023.
  • 104 funds tracked by Wall St. Rank held Definium Therapeutics as of Q4 2023.

Based on Impact Partnership Wealth's 13F filing for Q4 2023, filed 14 Feb 2024.